Isolated plasma EVs from this cohort of 60 rectal cancer patients have been characterized previously by NTA, TEM and Western blot analysis (presence of CD63, CD9, ALIX and APOA1 and the absence of GM130) and shown to contain mutated mtDNA (Bjørnetrø et al. This evidence concerns the gene CD9 and rectal cancer.